LSDAF yields 2.07% · JNJ yields 2.14%● Live data
📍 LSDAF pulled ahead of the other in Year 1
Combined, LSDAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LSDAF + JNJ for your $10,000?
Lassonde Industries Inc., together with its subsidiaries, develops, produces, and markets a range of ready-to-drink fruit juices and drinks, and frozen juice concentrates in Canada, the United States, and internationally. The company offers pure juices, fruit drinks, cranberry sauces, fruit-based snacks, pasta sauces, bruschetta toppings, tapenades, and pestos. In addition, it produces apple cider and cider-based beverages; and imports and markets selected wines. The company sells its products in various packages under various trademarks, including Antico, Apple & Eve, Arte Nova, Bombay, Canton, Double Vie, Dublin's Pub, Everfresh, Fairlee, Fruité, Grown Right, Kiju, Mont-Rouge, Northland, Oasis, Old Orchard, Orange Maison, Rougemont, Ruby Kist, Sun-Rype, The Switch, Tropical Grove, Allen's, Arizona, Del Monte, Graves, Nature's Best, and Tetley. It serves supermarket chains, independent grocers, superstores, warehouse clubs, pharmacy chains, restaurants, hotels, hospitals, schools, and wholesalers, as well as sells online. The company was founded in 1918 and is headquartered in Rougemont, Canada.
Full LSDAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.